Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is in the list of top stocks to trade today as the company shares are trading 0.67% or 0.22 points up from last closing price of $32.94, reaching $33.16 at last check. The AXNX share price has risen in 3 of the last 5 days and is up 11.8% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -50,300 shares, and in total 67100 shares valued at $2.225 million were seen changing hands compared with 117400 shares valued at $3.867 million recorded at the previous session. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes in AXNX stock for the next couple of days.
Axonics Modulation Technologies, Inc. (AXNX) shares have notched a 3-month gain of about 11.8%, but has still advanced 132.63% year to date. By comparison, the stock sank 0% over the past 12 months, while it slipped -12.48% over the 1 month. The company’s market cap is around $981.74M, with its short interest ratio standing at 7.46%.
In the current trading session for AXNX, the stock witnessed two major price actions, it rose to a high of $34.66 and was down as much as $33.06 at one point. The high recorded is very low when compared to their 52-week high which is $11.95. The 52-week high is now at -21.17 distance from current price. Their recent low of $43.37 represents a 186.11% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for AXNX is $40.67, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of Axonics Modulation Technologies, Inc. earned $-1.8 per share in the trailing 12 months and has a P/E ratio of -18.42. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 33.28 and lower compared to the sector’s average of 33.85. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. AXNX also has P/S multiple of 514.53. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 6.58x.
The company recorded an interesting insider purchase transaction by the CEO on Aug 06, 2019. A Securities and Exchanges Commission filings show that Raymond W Cohen bought a total of 3,500 AXNX shares that day for a sum of around $106,435. Axonics Modulation Technologies, Inc. (AXNX) insiders have acquired 10,501 shares in the stock within the past three months. In total, individual insiders traded 22,196 shares in the business, which makes up 0.073% of 30,360,682 shares that were traded over a year. In the past 12 months, insiders have purchased 30,335,225 shares while the seller parted with 25,457 shares.
AXNX‘s last price was up 43.95% as compared to the average trading price of 50 days recorded at $23.04 while enlarging the period to 200 trading days, the average closing price was $35.5. At present, there are 27.93 million in the total number of common shares owned by the public and among those 17.92 million shares have been available to trade. The percentage of shares being held by the company management was 4% while institutions stake was 74.7%. The company has generated negative returns on equity over the last 12 months (-65.8%). It managed to keep its gross profit margin at 49.3% over the past 12 months.
When assessing the full upside of the AXNX stock, there is another set of technicals that should be looked into and considered. Its -5.37% decline from moving average of $35.04 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.
Most of the analysts surveyed by Thomson/First Call think quite highly of Axonics Modulation Technologies, Inc. — 4 analysts rate the stock as a buy with another 0 rating it strong buy. There are 0 analysts who maintain a hold rating for the stock, with 0 giving it a sell rating. Analysts arrived at a 12-month price target of $32.48 on shares of Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), which corresponds to 3.51% downside potential than its current market price of $33.16 and implies potential despite the recent advance in the price. However, their current target price has fallen from $32.48 a month ago and is up handily from the consensus target of $23.23 a quarter ago.